← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2012Last known activity
Nov 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT07177053Lead sponsorPhase 2Nov 30, 2025
- NCT07177053Sponsor investigatorPhase 2Nov 30, 2025
- NCT05194007CollaboratorPhase 2/Phase 3Feb 19, 2022
- NCT04645303Study chairEarly Phase 1Nov 6, 2020
- NCT04645303Reponsible party - principal investigatorEarly Phase 1Nov 6, 2020
- NCT04645303Lead sponsorEarly Phase 1Nov 6, 2020
- NCT04443387Reponsible party - principal investigatorN/AApr 1, 2012
- NCT04443387Lead sponsorN/AApr 1, 2012
Details
- Last known activity
- Nov 30, 2025